Jale Karolyi‐Oezguer
Boehringer Ingelheim (Austria)(AT)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Catalytic C–H Functionalization Methods, Cancer-related Molecular Pathways, Peptidase Inhibition and Analysis, Ubiquitin and proteasome pathways
Most-Cited Works
- → BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design(2019)560 cited
- → Drugging an undruggable pocket on KRAS(2019)420 cited
- → Targeting cancer with small-molecule pan-KRAS degraders(2024)141 cited
- → Discovery of Novel Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2–p53 Interaction(2016)119 cited
- → Targeted Synthesis of Complex Spiro[3H‐indole‐3,2′‐pyrrolidin]‐2(1H)‐ones by Intramolecular Cyclization of Azomethine Ylides: Highly Potent MDM2–p53 Inhibitors(2018)28 cited
- → Reply to Tran et al.: Dimeric KRAS protein–protein interaction stabilizers(2020)19 cited
- → Publisher Correction: BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design(2019)16 cited
- → Targeting cancer with small molecule pan-KRAS degraders(2023)15 cited
- → Synthesis of Indazoles via N–N Bond-Forming Oxidative Cyclization from 2-Aminomethyl-phenylamines(2024)8 cited
- → Synthesis of MDM2-p53 Inhibitor BI-0282 via a Dipolar Cycloaddition and Late-Stage Davis–Beirut Reaction(2022)5 cited